10x Genomics
TXG
TXG
264 hedge funds and large institutions have $2.36B invested in 10x Genomics in 2024 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 104 increasing their positions, 72 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 259 → 264 (+5)
1.64% less ownership
Funds ownership: 99.74% → 98.1% (-1.6%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
264
Holding in Top 10
2
Calls
$6.36M
Puts
$2.06M
Top Buyers
| 1 | +$50.6M | |
| 2 | +$29.7M | |
| 3 | +$25.4M | |
| 4 |
DM
Deerfield Management
New York
|
+$18.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.2M |
Top Sellers
| 1 | -$56.1M | |
| 2 | -$55.9M | |
| 3 | -$48M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$19.6M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$11.5M |